Vendor, Niwot, CO
Vesicle Therapeutics Inc.
UEI KALZFKXVQTA6, CAGE 8UT94
1 award and $0 obligated between July 2, 2024 and July 2, 2024, 100% under full and open competition, against 5.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N95022C00020Definitive Contract, July 2, 2024, Full and Open Competition After Exclusion of Sources, 5 offers | National Institutes of Health NidaNational Institutes of Health | Neurotropic Gectosomes as a CNS Gene Delivery System for Ad/Adrd Therapy DevelopmentNAICS 541714, PSC AN11 | $0 |
- Places of performance
- Colorado
- Product and service codes
- AN11 Health R&D Services; Health Care Services; Basic Research
- Transactions
- 1 across 1 awards